Supportive and Palliative Care Research

The Supportive and Palliative Care Research program supports studies on the prevention or treatment of acute and chronic symptoms and morbidities related to cancer and its treatment. This includes the impact on the quality of life of patients and their informal caregivers. The program also supports studies of patients and their caregivers at the end of life.

View the video, Cancer Pain Research: Ann O'Mara, PhD, RN, MPH, to learn more.

News and Information

  • News
  • Information

Read more

Topic Areas (more to come)

Anorexia, Cachexia, Cardiotoxicity, Caregiver Issues, Cognitive Dysfunction, Distress/Anxiety/Depression, End of Life, Fatigue, Geriatrics, Hot Flashes, Lymphedema, Medication Adherence, Mucositis, Multiple Symptoms, Musculoskeletal Symptoms, Nausea, Neuropathy, Nutrition, Oral Complications, Other Supportive Care Issues, Pain, Palliative Care, Pediatrics/Adolescents/Young Adult, Physical Functioning, Quality of Life, Skin Toxicities, Sleep Disorders, Urinary Complications

The Opioid Epidemic and Cancer Pain Management: A Conversation with Dr. Judith Paice

POSTED: July 16, 2018

Judith Paice, PhD, RN, director of the Cancer Pain Program, Northwestern University Feinberg School of Medicine.Pain is a common symptom in cancer patients. It can be caused by cancer, its treatments, or a combination of factors. Although some pain lasts a relatively short time and will resolve on its own, cancer or its treatments can also lead to long-lasting, chronic pain. Opioid medications are an important component of managing some types of unrelieved cancer pain.

Read the article

Sodium Thiosulfate Prevents Cisplatin-Induced Hearing Loss in Some Children

POSTED: July 13, 2018

An inner ear "organoid" showing hair cells (red) and hair cell bundles (yellow).The drug sodium thiosulfate can protect the hearing of children with cancer undergoing treatment with the chemotherapy drug cisplatin, results from a new study show.

The clinical trial involved children with liver cancer that had not spread (localized cancer), for whom cisplatin is the standard chemotherapy. Although cisplatin is very effective, it also causes hearing loss in many children.

Read the article